Autologous HSCT in systemic sclerosis: a step forward

MeSH terms

• Clinical Trials, Phase II as Topic
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / therapeutic use*
• Disease Progression
• Drug Administration Schedule
• Early Termination of Clinical Trials
• Europe
• Hematopoietic Stem Cell Transplantation* / mortality
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / therapeutic use*
• Randomized Controlled Trials as Topic
• Research Design
• Scleroderma, Systemic / drug therapy*
• Scleroderma, Systemic / immunology
• Scleroderma, Systemic / surgery*
• Therapeutic Equipoise
• Transplantation, Autologous
• Treatment Outcome